65,437 trials
Non-small Cell Lung Cancer
Primary: Percentage of Participants With a Best Overall Response of Complete Response (CR), Partial Response (PR), Stable Disease (SD), or Progressive Disease (PD) — 0.0; 0.0…
Constipation
Primary: Change From Baseline in the Weekly Average of Spontaneous Bowel Movements (SBMs) During Treatment — 1.40; 2.58 Number of SBMs/week
Breast Cancer
Primary: To Determine the Maximum Tolerated Doses (MTD) and Dose-limiting Toxicities (DLT) of LBH589 in Combination With Capecitabine When Administered to Patients With…
Non-Hodgkin's Lymphoma
Primary: Percentage of Participants With an Adverse Event (AE) - Overall Summary — 67.4; 5.8; 20.2; 0.2 percentage of participants
Hepatitis C, Chronic
Primary: Number of Participants With Interleukin 28B (IL28B) Genotype rs12979860 by Cirrhosis Status and Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Genotype: Treatment-Naive…
Gastrointestinal Carcinoid Tumor · Islet Cell Tumor · Neoplastic Syndrome
Primary: Four-month Progression-free Survival Rate — 78.5 percentage of participants — p=<0.001
Atrial Fibrillation
Primary: The Primary Effectiveness Endpoint is the Successful Navigation and EGM Recording of Each Pre-specified Pulmonary Vein Per Procedure Between Both the Control and the…
Meningococcal Vaccine
Primary: Percentage of Participants Achieving Serum Bactericidal Assay Using Human Complement (hSBA) Titer Greater Than or Equal to (>=) Lower Limit of Quantitation: Group 1 and…
Physical Activity
Primary: Minutes of Moderate or Vigorous Physical Activity Per Week After 12-months — 246; 156 minutes per week moderate-to-vigorous PA
Glaucoma
Primary: Intraocular Pressure — 14.7; 12.7 mm Hg
Postoperative Nausea
Primary: Post-operative Nausea and Vomiting
Cytomegalovirus Infections
Primary: Number of Participants With Endpoint Committee (EC)-Confirmed Cytomegalovirus (CMV) Disease Within 6 Months Post-Transplantation — 14; 10 number of participants with…
Refractive Error
Primary: Subjective Ease of Lens Removal — 45; 76; 23; 34 participants
Generalized Chronic Periodontitis
Primary: Percentage of True Positive/Negative aMMP-8 Tests of All Periodontitis Patients (Sensitivity/Specificity) — 87; 60 percentage of true cases (sens./spec.)
Transcutaneous Bilirubinometry
Primary: In This Study, the Investigators Plan to Test the Performance of a Novel Transcutaneous Device (BiliCareTM) to Screen for Bilirubin Levels at Postnatal Age of 12 to 48…